Yang, D., Oh, S. Y., Jeon, Y., Song, G., Kim, S., Yoon, S. E., Kim, T., Lee, J. H., Kim, H. R., Koh, Y., Song, H., Lee, M., Kim, W. S. (2025). NB02 (Poseltinib) combined rituximab and lenalidomide in R/ R PCNSL (POTENTIAL-P): Initial results of safety lead-in cohort.. Blood. https://doi.org/10.1182/blood-2025-5463